Evidence map›Paper›PMID 23349902›Full record

ArticlePloS one2013

A potential role for plasma uric acid in the endothelial pathology of Plasmodium falciparum malaria.

Neida K Mita-Mendoza, Diana L van de Hoef, Tatiana M Lopera-Mesa, Saibou Doumbia, Drissa Konate, Mory Doumbouya, Wenjuan Gu, Jennifer M Anderson, Leopoldo Santos-Argumedo, Ana Rodriguez and 4 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00669084 (Studies of Innate and Acquired Resistance to P. Falciparum Malaria in Mali), which is not on this map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00669084 completednot on this map

Studies of Innate and Acquired Resistance to P. Falciparum Malaria in Mali

TypeobservationalSponsorNational Institute of Allergy and Infectious Diseases (NIAID)Ran2008 to 2013Enrolled1,718ConditionsMalaria
3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it, 23 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Oxidative Stress in Malaria: Potential Benefits of Antioxidant Therapy.International journal of molecular sciences · 2022
    Review
  6. Biochemical characteristics of patients with imported malaria.Frontiers in cellular and infection microbiology · 2022
    Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 3 countries.

Neida K Mita-MendozaLaboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland, USA.
Diana L van de Hoef
Tatiana M Lopera-Mesa
Saibou Doumbia
Drissa Konate
Mory Doumbouya
Wenjuan Gu
Jennifer M Anderson
Leopoldo Santos-Argumedo
Ana Rodriguez
Michael P Fay
Mahamadou Diakite
Carole A Long
Rick M Fairhurst
National Institutes of Health · USUniversity of Bamako · MLNational Institute of Allergy and Infectious Diseases · USNew York University · USInstituto Politécnico Nacional · MX

Funding

MEDICAL SCIENTIST TRAINING PROGRAMT32GM007250 · NIGMS · CASE WESTERN RESERVE UNIVERSITY · PI HUANG, ALEX YEE-CHEN · 1985 to 2023
$33.4M
Mali International Center for Excellence in Research: Vectors and Hosts of Parasitic Infectious DiseasesZIAAI001062 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI LEHMANN, TOVI · 2009 to 2025
$17.3M
Host Immune Responses to Antigens of Malaria ParasitesZIAAI001020 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI LONG, CAROLE · 2009 to 2025
$13.6M
Malaria Pathogenesis and Human ImmunityZIAAI001000 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI FAIRHURST, RICK · 2009 to 2017
$9.3M
Intramural NIH HHSNIGMS NIH HHS T32 GM007250
6 · The paper itself

Abstract

backgroundInflammatory cytokinemia and systemic activation of the microvascular endothelium are central to the pathogenesis of Plasmodium falciparum malaria. Recently, 'parasite-derived' uric acid (UA) was shown to activate human immune cells in vitro, and plasma UA levels were associated with inflammatory cytokine levels and disease severity in Malian children with malaria. Since UA is associated with endothelial inflammation in non-malaria diseases, we hypothesized that elevated UA levels contribute to the endothelial pathology of P. falciparum malaria. METHODOLOGY/PRINCIPAL

findingsWe measured levels of UA and soluble forms of intercellular adhesion molecule-1 (sICAM-1), vascular cell adhesion molecule-1 (sVCAM-1), E-selectin (sE-Selectin), thrombomodulin (sTM), tissue factor (sTF) and vascular endothelial growth factor (VEGF) in the plasma of Malian children aged 0.5-17 years with uncomplicated malaria (UM, n = 487) and non-cerebral severe malaria (NCSM, n = 68). In 69 of these children, we measured these same factors once when they experienced a malaria episode and twice when they were healthy (i.e., before and after the malaria transmission season). We found that levels of UA, sICAM-1, sVCAM-1, sE-Selectin and sTM increase during a malaria episode and return to basal levels at the end of the transmission season (p<0.0001). Plasma levels of UA and these four endothelial biomarkers correlate with parasite density and disease severity. In children with UM, UA levels correlate with parasite density (r = 0.092, p = 0.043), sICAM-1 (r = 0.255, p<0.0001) and sTM (r = 0.175, p = 0.0001) levels. After adjusting for parasite density, UA levels predict sTM levels. CONCLUSIONS/SIGNIFICANCE: Elevated UA levels may contribute to malaria pathogenesis by damaging endothelium and promoting a procoagulant state. The correlation between UA levels and parasite densities suggests that parasitized erythrocytes are one possible source of excess UA. UA-induced shedding of endothelial TM may represent a novel mechanism of malaria pathogenesis, in which activated thrombin induces fibrin deposition and platelet aggregation in microvessels. This protocol is registered at clinicaltrials.gov (NCT00669084).

Indexed as

Plasmodium falciparumEndotheliumErythrocytesE-SelectinFibrinHumansInflammationIntercellular Adhesion Molecule-1Malaria, FalciparumMicrovesselsPlatelet AggregationThrombomodulinUric AcidVascular Cell Adhesion Molecule-1E-SelectinFibrinIntercellular Adhesion Molecule-1THBD protein, humanThrombomodulinUric AcidVascular Cell Adhesion Molecule-1

Identifiers

PMID23349902
PMCPMC3551755
OpenAlexW2056382227

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.